Literature DB >> 9261311

Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction.

J Pe'er1, M Neufeld, M Baras, H Gnessin, A Itin, E Keshet.   

Abstract

PURPOSE: Iris neovascularization (rubeosis iridis) is a common finding in eyes harboring retinoblastoma. The purpose of the current study is to evaluate the histologic factors that may affect the development of rubeosis iridis in eyes with retinoblastoma and to examine whether vascular endothelial growth factor (VEGF), a hypoxia-induced angiogenic factor, is produced by hypoxic retinoblastoma and retinal cells in these eyes.
MATERIALS AND METHODS: One hundred eighty-one enucleated eyes containing retinoblastoma were the source for the current study. Histologic slides were evaluated for the presence and degree of rubeosis iridis as well as for other histologic factors. Univariate and multivariate statistical analyses were performed to find a correlation between rubeosis iridis and the other histologic factors. Eight of the eyes underwent in situ hybridization with a specific VEGF mRNA probe to locate tumor and retinal cells that may produce this hypoxia-induced angiogenic factor.
RESULTS: The amount of tumor necrosis as well as choroidal and optic nerve invasion was found to be one of the most important factors that correlated with the presence and degree of rubeosis iridis in the examined eyes. All eight eyes that underwent in situ hybridization analysis showed strong signals of VEGF mRNA in retinoblastoma cells around necrotic regions and in the outer nuclear layers in areas of detached retina.
CONCLUSIONS: There exists an association between rubeosis iridis and histologic factors found in advanced stages of retinoblastoma, especially the amount of tumor necrosis. Vascular endothelial growth factor may well be an angiogenic factor that is secreted by the hypoxic retinoblastoma and retinal cells and, reaching the iris, causes (presumably in collaboration with other factors) rubeosis iridis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261311     DOI: 10.1016/s0161-6420(97)30150-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Unilateral sporadic retinal dysplasia: results of histopathologic, immunohistochemical, chromosomal, genetic, and VEGF-A analyses.

Authors:  Frederick A Jakobiec; Fouad R Zakka; Robert D'Amato; Margaret M Deangelis; David S Walton; Rajesh C Rao
Journal:  J AAPOS       Date:  2011-12       Impact factor: 1.220

Review 2.  Vasculogenic mimicry and tumor angiogenesis.

Authors:  R Folberg; M J Hendrix; A J Maniotis
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: correlation between clinical, MR imaging, and histopathologic findings.

Authors:  P de Graaf; P van der Valk; A C Moll; S M Imhof; A Y N Schouten-van Meeteren; D L Knol; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

4.  Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.

Authors:  Martha Kim; Jeong Hun Kim; Jin Hyoung Kim; Dong Hun Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2010-02-05

5.  Peripapillary subretinal neovascularization in retinoblastoma.

Authors:  Satoru Kase; Jignesh G Parikh; Narsing A Rao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-13       Impact factor: 3.117

6.  Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.

Authors:  E Ferrari Marback; V E A Arias; A Paranhos; F A Soares; A L Murphree; C M Erwenne
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

7.  Basic fibroblast growth factor impact on retinoblastoma progression and survival.

Authors:  Colleen M Cebulla; Maria-Elena Jockovich; Yolanda Piña; Hinda Boutrid; Armando Alegret; Amy Kulak; Abigail S Hackam; Sanjoy K Bhattacharya; William J Feuer; Timothy G Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-09       Impact factor: 4.799

8.  Higher vessel densities in retinoblastoma with local invasive growth and metastasis.

Authors:  Jochen Rössler; Torsten Dietrich; Helena Pavlakovic; Lothar Schweigerer; Werner Havers; Andreas Schüler; Norbert Bornfeld; Harald Schilling
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

9.  Transforming growth factor beta in retinoblastoma-related cataract.

Authors:  Satoru Kase; Jignesh G Parikh; Peter N Youssef; A Linn Murphree; Narsing A Rao
Journal:  Arch Ophthalmol       Date:  2008-11

10.  Guidelines for imaging retinoblastoma: imaging principles and MRI standardization.

Authors:  Pim de Graaf; Sophia Göricke; Firazia Rodjan; Paolo Galluzzi; Philippe Maeder; Jonas A Castelijns; Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2011-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.